AstraZeneca 2Q: Soriot's In It For The Long Haul

Pascal Soriot
Pascal Soriot is staying put at AstraZeneca as CEO
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Business